English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Sir, Liposome-encapsulated doxorubicin (DOX-SL) is highly eŒective and relatively safe for the treatment of AIDS-related Kaposi’s sarcoma (KS). Myelosuppression, nausea and diarrhoea comprise the most frequent systemic side-eŒects of DOX-SL (1, 2). We report herein for the  rst time the case of a 34-year-old Caucasian man who developed extensive psoriasiform pustular eruptions during treatment with DOX-SL.

Psoriasiform Pustular Eruptions from Pegylated-liposomal Doxorubicin in AIDS-related Kaposi's Sarcoma